Alkermes plc. 8K

Alkermes plc amended its senior credit agreement to reprice its Tranche A term loans and refinance its Tranche B term loans into a new 2026 Refinancing Tranche B Term Facility of approximately $773 million on August 12, 2026.

On August 12, 2026, Alkermes plc and certain subsidiaries entered into Amendment No. 1 to their February 12, 2026 Credit Agreement with JPMorgan Chase Bank, N.A. and other lenders, which (i) reduces the Applicable Rate on the Initial Tranche A Term Loans (a repricing of Tranche A) and (ii) refinances all outstanding Initial Tranche B Term Loans into a new $773,062,500 2026 Refinancing Tranche B Term Facility through a combination of conversions by existing Tranche B lenders and new Tranche B commitments provided primarily by JPMorgan, together with conforming amendments to the Credit Agreement and related exhibits, subject to customary closing conditions and reaffirmations of guarantees and collateral.

Filing Facts

CIK

1520262

Ticker

ALKS

Form

8K

Source Type

fda

Accession

0001193125-26-345901

Alert Tier

7